ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SGRY vs MD // EV/EBITDA & P/E VALUATION

Surgery Partners Inc. (NASDAQ) VS. Pediatrix Medical Group Inc. (NYSE) • 15-METRIC TALLY: SGRY 3 — MD 4
▲ EV/EBITDA & P/E VALUATION LEADER: MD
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SGRY VS. MD) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SGRY MD SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 9.90% 33.60% -23.70 MD /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 9.7x 9.6x +0.10 MD /valuation <GO>
Free Cash Flow Yield 6.44% 11.43% -4.99 MD /fcf-yield <GO>
Operating Margin 45.80% — — TIE /operating-margins <GO>
Net Profit Margin -9.20% — — TIE /net-margins <GO>
Revenue Growth (YoY) 6.60% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.67 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 8/9 6/9 +2.00 SGRY /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 86.2 71.7 +14.53 SGRY /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.99 — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 22.0x 13.3x +8.70 MD /forward-pe <GO>
Enterprise Scale & Market Cap $3.04B $2.37B $667.6M SGRY /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SGRY REV MD REV SGRY GROSS % MD GROSS % SGRY FCF MD FCF
FY 2025 $0 $0 — — $195.6M $271.1M
FY 2024 $0 $0 — — $209.7M $206.6M
FY 2023 $0 $0 — — $293.8M $137.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SGRY // BETA 0.99
MD // BETA —